Below are the studies currently ongoing at Pepose Vision Institute.
Please complete our Clinical Studies Application if you are interested in seeing if you qualify for one of our studies.
Be sure to check back often as we add new studies all the time.
For more information, contact
Lee Stolze, CCRC
Clinical Research Manager
Lifelong Vision Foundation at Pepose Vision Institute
Direct: 636.534.5126. Fax: 636.534.5106
1815 Clarkson Road Chesterfield, MO 63017
AMD (Age-Related Macular Degeneration) Dry or Wet
• TOGA (University of Virginia): Low-dose oral (pill) doxycycline for slowing the progression of
advance Geographic Atrophy due to Dry AMD
• IMT-PAS Telescopic Lens (Vision Care Technologies): A registry study of the implantable (device)
miniature telescope for advanced AMD
• EyeGate (EyeGate Pharma): Comparing two delivery systems of an ophthalmic solution or suspension in patients with Non-Infectious Uveitis. The EyeGate study stipend is $100.00 per completed visit, six visits
• Synchronize (Shire): Potential new drug targeting the two main causes of Pink Eye, adenoviral and bacterial.
Signs and symptoms for no more than the past 3 days and be untreated. The Shire study stipend is $50.00 each completed visit, five visits.
What's your next step?
If you are interested in one of our studies or would like to learn more,
please click below and complete our brief Clinical Studies Application or call Lee Stolze at (636) 534.5126.